Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
FLAG Therapeutics, Inc. logo — company profile

FLAG Therapeutics, Inc.

Founded 2013 2 employees Series Unknown Health and Wellness, Pharmaceutical

General Information

Company Name FLAG Therapeutics, Inc.
Founded Year 2013
Employees 2
Industries Health and Wellness, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when FLAG Therapeutics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About FLAG Therapeutics, Inc.

FLAG Therapeutics, Inc., an early-stage oncology company based in Raleigh, North Carolina, focuses on developing therapies using two novel classes of small molecule, water-soluble drugs. In vivo studies indicate that its antiangiogenic/anti-tubulin (AA/AT) compounds and folate-targeted anti-cancer (FTAC) compounds have the potential to treat multiple cancer types more safely and effectively than conventional therapies. Notably, FLAG Therapeutics has secured exclusive worldwide rights to these compounds from Duquesne University. Founded in 2013, the company operates in the Health and Wellness and Pharmaceutical industries. As of now, there is no available information regarding the last investment or the investors associated with FLAG Therapeutics.

No funding data available for FLAG Therapeutics, Inc. yet.

Get notified when FLAG Therapeutics, Inc. raises funding

FLAG Therapeutics, Inc. Alternatives & Competitors

FLAG Therapeutics, Inc. vs
Asylia Therapeutics
Asylia Therapeutics

Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious diseases.

Series A
1 employees
Biotechnology, Health Care
FLAG Therapeutics, Inc. vs
Kintara Therapeutics, Inc. NASDAQ: KTRA
Kintara Therapeutics, Inc. NASDAQ: KTRA United States

Seeking New Horizons for Cancer Patients

Grant
8 employees
Biotechnology, Health Care
FLAG Therapeutics, Inc. vs
January Therapeutics
January Therapeutics United States

Transformational Oncology

Series Unknown
2 employees
Biotechnology, Health Care

FAQ About FLAG Therapeutics, Inc.

FLAG Therapeutics Inc., headquartered in Raleigh, North Carolina, is an early-stage oncology company focused on the development of therapies based on two novel classes of small molecule, water-soluble drugs. In vivo studies suggest that both classes of compounds, antiangiogenic/ anti-tubulin (AA/...
FLAG Therapeutics, Inc. was founded in 2013.
FLAG Therapeutics, Inc. operates in the following industries: Health and Wellness, Pharmaceutical.
FLAG Therapeutics, Inc. has approximately 2 employees.
Top alternatives and competitors to FLAG Therapeutics, Inc. include Asylia Therapeutics, Kintara Therapeutics, Inc. NASDAQ: KTRA, January Therapeutics, CUROGEN, Eigen Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FLAG Therapeutics, Inc. and Asylia Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors FLAG Therapeutics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy